Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2018

Open Access 01-12-2018 | Research

Predictors of 25-hydroxyvitamin D status among individuals with metabolic syndrome: a cross-sectional study

Authors: Séphora Louyse Silva Aquino, Aline Tuane Oliveira da Cunha, Hermilla Torres Pereira, Erika Paula Silva Freitas, Ana Paula Trussardi Fayh, Josivan Gomes Lima, Severina Carla Vieira Cunha Lima, Karine Cavalcanti Maurício Sena-Evangelista, Lucia Fátima Campos Pedrosa

Published in: Diabetology & Metabolic Syndrome | Issue 1/2018

Login to get access

Abstract

Background

The risk of metabolic syndrome can be influenced by inadequate vitamin D levels, and exposure to sunlight is the main external source of vitamin D. The present study assessed the influence of environmental, biological, and nutritional factors in relation to seasonal 25-hydroxyvitamin D (25OHD) concentration in individuals with metabolic syndrome.

Methods

This cross-sectional study enrolled 180 individuals with metabolic syndrome aged between 18 and 80 years. The 25OHD concentration was considered the dependent variable; independent variables included age, sex, skin color, use of sunscreen, skin type, sun exposure score, ultraviolet radiation index, geographic location, season, body mass index, waist:hip ratio, waist circumference, parathyroid hormone level, total serum calcium level, and calcium and vitamin D intake.

Results

The average vitamin D in individuals evaluated in summer 32 ± 10 ng/mL was greater than in the winter 26 ± 8 ng/mL (p < 0.017). HDL-cholesterol was the only component of the MetS that differed significantly between the seasons (p < 0.001), showing higher concentrations in autumn 45 ± 8 mg/dL than in summer 35 ± 8 mg/dL. In the multiple regression model, gender, WHR, sun exposure score, and winter vs. summer explained 10% of the variation in 25OHD concentration (p = 0.004).

Conclusions

Sex, waist:hip ratio, sun exposure, and summer season were predictors of 25OHD status among individuals with metabolic syndrome. HDL-cholesterol was the only component of metabolic syndrome that differed significantly between the seasons.
Appendix
Available only for authorised users
Literature
3.
go back to reference Sa NNB, Moura EC. Fatores associados à carga de doenças da síndrome metabólica entre adultos brasileiros. Rep Public Health. 2010;26:1853–62. Sa NNB, Moura EC. Fatores associados à carga de doenças da síndrome metabólica entre adultos brasileiros. Rep Public Health. 2010;26:1853–62.
9.
go back to reference Kamezake F, Sonodal S, Nakatal S, Muraokal Y, Okazakil M, Tamural M, et al. Association of seasonal variation in the prevalence of metabolic syndrome with insulin resistance. Hypertens Res. 2013;36:398–402.CrossRef Kamezake F, Sonodal S, Nakatal S, Muraokal Y, Okazakil M, Tamural M, et al. Association of seasonal variation in the prevalence of metabolic syndrome with insulin resistance. Hypertens Res. 2013;36:398–402.CrossRef
16.
go back to reference Holick MF. Biological effects of sunlight, ultraviolet radiation, visible light, infrared radiation and vitamin D for health. Anticancer Res. 2016;36:1345–56.PubMed Holick MF. Biological effects of sunlight, ultraviolet radiation, visible light, infrared radiation and vitamin D for health. Anticancer Res. 2016;36:1345–56.PubMed
19.
go back to reference National Cholesterol Education Program Adult Treatment Panel III. NCEP-ATP III). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III. JAMA. 2001;285:2486–97.CrossRef National Cholesterol Education Program Adult Treatment Panel III. NCEP-ATP III). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III. JAMA. 2001;285:2486–97.CrossRef
20.
go back to reference World Health Organization (WHO). Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report. 894th ed. Geneva: World Health Organization; 2000. p. 265. World Health Organization (WHO). Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report. 894th ed. Geneva: World Health Organization; 2000. p. 265.
21.
go back to reference VI Brazilian Guideline on Hypertension. Brazilian Society of Cardiology; Brazilian Society of Hypertension; Brazilian Society of Nephrology. Arq Bras Cardiol. 2009/2010;95:1–51. VI Brazilian Guideline on Hypertension. Brazilian Society of Cardiology; Brazilian Society of Hypertension; Brazilian Society of Nephrology. Arq Bras Cardiol. 2009/2010;95:1–51.
23.
go back to reference Instituto Brasileiro de Geografia e Estatística (IBGE). Características étnico-raciais da população: um estudo das categorias de classificação de cor ou raça. Rio de Janeiro; 2011. Instituto Brasileiro de Geografia e Estatística (IBGE). Características étnico-raciais da população: um estudo das categorias de classificação de cor ou raça. Rio de Janeiro; 2011.
24.
go back to reference Fitizpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–71.CrossRef Fitizpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–71.CrossRef
25.
go back to reference World Health Organization (WHO). Global solar UV index: a practical guide. A joint recommendation of World Health Organization, World Meteorological Organization, United Nations Environment Programme and the International Commission on Non-Ionizing Radiation Protection. Geneva: WHO; 2002. World Health Organization (WHO). Global solar UV index: a practical guide. A joint recommendation of World Health Organization, World Meteorological Organization, United Nations Environment Programme and the International Commission on Non-Ionizing Radiation Protection. Geneva: WHO; 2002.
26.
go back to reference Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr. 2001;55:1091–7.CrossRefPubMed Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr. 2001;55:1091–7.CrossRefPubMed
27.
go back to reference Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of LDL cholesterol in plasma without use the preparative ultracentrifugue. Clin Chem. 1972;18:499–504.PubMed Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of LDL cholesterol in plasma without use the preparative ultracentrifugue. Clin Chem. 1972;18:499–504.PubMed
31.
36.
go back to reference Chen SH, Jen IA, Chuang SY, Lin KC, Chou P. Community-based study on summer-winter differences of component of metabolic syndrome in Kinmen, Taiwan. Prev Med. 2006;43(2):129–35.CrossRefPubMed Chen SH, Jen IA, Chuang SY, Lin KC, Chou P. Community-based study on summer-winter differences of component of metabolic syndrome in Kinmen, Taiwan. Prev Med. 2006;43(2):129–35.CrossRefPubMed
39.
go back to reference Jorde R, Grimnes G. Exploring the association between serum 25-hydroxyvitamin D and serum lipids-more than confounding? Eur J Clin Nutr. 2018;72(4):526–33.CrossRefPubMed Jorde R, Grimnes G. Exploring the association between serum 25-hydroxyvitamin D and serum lipids-more than confounding? Eur J Clin Nutr. 2018;72(4):526–33.CrossRefPubMed
Metadata
Title
Predictors of 25-hydroxyvitamin D status among individuals with metabolic syndrome: a cross-sectional study
Authors
Séphora Louyse Silva Aquino
Aline Tuane Oliveira da Cunha
Hermilla Torres Pereira
Erika Paula Silva Freitas
Ana Paula Trussardi Fayh
Josivan Gomes Lima
Severina Carla Vieira Cunha Lima
Karine Cavalcanti Maurício Sena-Evangelista
Lucia Fátima Campos Pedrosa
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2018
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-018-0346-1

Other articles of this Issue 1/2018

Diabetology & Metabolic Syndrome 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.